These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6219023)

  • 1. Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes.
    Paik SG; Blue ML; Fleischer N; Shin S
    Diabetes; 1982 Sep; 31(9):808-15. PubMed ID: 6219023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functions.
    Blue ML; Shin SI
    Diabetes; 1984 Feb; 33(2):105-10. PubMed ID: 6229438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.
    Paik SG; Fleischer N; Shin SI
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6129-33. PubMed ID: 6449703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice.
    Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R
    Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple low-dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune response.
    McEvoy RC; Thomas NM; Hellerström C; Ginsberg-Fellner F; Moran TM
    Diabetologia; 1987 Apr; 30(4):232-8. PubMed ID: 2954873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunity to streptozocin. Cellular requirements for induction of lymphoproliferation.
    Klinkhammer C; Popowa P; Gleichmann H
    Diabetes; 1988 Jan; 37(1):74-80. PubMed ID: 2961642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
    Buschard K
    Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic studies on the induction of diabetes in experimental animals. Cellular basis for the induction of diabetes by streptozotocin.
    Kim YT; Steinberg C
    Diabetes; 1984 Aug; 33(8):771-7. PubMed ID: 6235141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens.
    Paik SG; Michelis MA; Kim YT; Shin S
    Diabetes; 1982 Aug; 31(8 Pt 1):724-9. PubMed ID: 6219020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin.
    Herold KC; Montag AG; Fitch FW
    Diabetes; 1987 Jul; 36(7):796-801. PubMed ID: 3556279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
    Leiter EH
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-lymphocytes transfer streptozotocin induced diabetes mellitus in mice.
    Buschard K; Rygaard J
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):277-82. PubMed ID: 310235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell function in mice injected with mononuclear splenocytes from multiple-dose streptozotocin diabetic mice.
    Arata M; Fabiano de Bruno L; Goncalvez Volpini WM; Quintans JC; D'Alessandro VG; Braun M; Basabe JC
    Proc Soc Exp Biol Med; 1994 May; 206(1):76-82. PubMed ID: 8183965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
    Zdravkovic N; Shahin A; Arsenijevic N; Lukic ML; Mensah-Brown EP
    Mol Immunol; 2009 Nov; 47(1):28-36. PubMed ID: 19356801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the diabetogenic effect of streptozotocin in part thymus-dependent?
    Buschard K; Rygaard J
    Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):23-7. PubMed ID: 152048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant mice.
    Kiesel U; Greulich B; Moumé CM; Kolb H
    Immunol Lett; 1981 Oct; 3(4):227-30. PubMed ID: 7309132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
    Zunino SJ; Simons LF; Sambrook JF; Gething MJ
    Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of helper and/or cytotoxic T-lymphocyte depletion on low-dose streptozocin-induced diabetes in C57BL/6J mice.
    Dayer-Métroz MD; Kimoto M; Izui S; Vassalli P; Renold AE
    Diabetes; 1988 Aug; 37(8):1082-9. PubMed ID: 3260567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.